Trial Profile
Clinical Trials Insight: 700025090
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Mar 2010
Price :
$35
*
At a glance
- Drugs KN 387271 (Primary)
- Indications Brain injuries; Stroke
- Focus Adverse reactions
- Sponsors KeyNeurotek Pharmaceuticals AG
- 20 Jul 2007 New trial record.